Thymus Cancer Market Forecast to 2030 Available in New Report
The Thymus
cancer market is expected to reach USD 583.6 Million by 2030
at 7.3% CAGR during the forecast period 2022-2030.
Thymus gland is a soft lymphoid organ situated between the lungs and
behind the breastbone. The main function of the thymus gland is secretion of
hormone thymosin. T cells or T lymphocytes are matured by the hormone thymosin.
These T cells are type of white blood cells and help body fight infections.
Thymus cancer can be classified into two types: Thymoma and Thymic carcinoma.
Thymoma is a condition where the cancerous cells have similar appearance as
normal thymus cells, whereas, thymic carcinoma cells possess different
appearance. Thymic cancer can be either
benign or malignant, depending on their penetration in other tissues and
organs. WHO segmented Thymoma into 6 different types based on the appearance of
tumour cell shape: type A, type AB, type B1, type B2, type B3 and type C
(Thymic Carcinoma). Thymoma is usually coupled with other autoimmune diseases
like myasthenia
gravis, thyroiditis and rheumatoid arthritis. Thymus cancer can be
diagnosed with chest X-rays, CT Scans and biopsy and can be removed surgically
if benign. Malignant Thymus cancer can be treated with Chemotherapy. Thymus
cancer is a rare cancer and according to American cancer society, there are
approximately 400 cases of thymus cancer every year.
Thymus cancer market size is likely to grow with increasing prevalence of
thymic cancer. Thymic cancer is mostly found in age group of 40-60 years, hence
with rising older population is likely to enhance the growth of thymus cancer
market. Additionally, growing demand for technological advancements and
innovative treatments along with growing government initiatives is likely to
drive the global thymus market.
However expensive treatment, and the side effects related to the
treatment of thymus cancer are likely to affect the growth of thymus cancer
market.
Major Key
Players:
This Thymus
Cancer Market Players are namely Amgen Inc. (US), Bristol-Myers Squibb Company (US), Celgene
Corporation (US), Eli Lilly and Company (US), Astellas Pharma Inc. (Japan),
Merck & Co., Inc. (US), Novartis AG (Switzerland), Pfizer Inc. (US),
AstraZeneca (UK), Mylan NV (US), Johnson & Johnson Services, Inc. (US),
Onxeo (France), Takeda Pharmaceutical Company Limited (Japan), Tiziana Life
Sciences plc (UK), and Teva Pharmaceutical Industries Ltd (Israel)
Segment Analysis
The MRFR analysis is segmented into four key dynamics for the convenience
of understanding;
By Types : Type A, Type AB, Type B1, Type B2, Type B3, and Thymic Carcinoma.
By Treatment : Surgery, Radiotherapy, and Chemotherapy among others.
By Care Centers : Hospitals, Clinics, Diagnostic Centers, and Research Laboratories among
others.
By Regions : North America, Europe, APAC, and the
Rest-of-the-World.
Regional Analysis
Although the North American region accounts
for the leading market for thymus cancer possessing the largest market share,
the European region is also a lucrative market for thymus cancer, following the
North American market closely. The market in these regions is fostered by the
increasing number of patients suffering from the disease, well-developed
technology, high healthcare expenditures, and the presence of leading market
players.
Moreover, the proliferated healthcare sector
alongside the growing thymus cancer markets in the countries such as the US,
Canada, Mexico, the UK, Germany, and France drive the market growth on a large
scale in Europe and North America.
The Asia Pacific market for thymus cancer is
expected to perceive an exponential growth, emerging as one of the promising
markets. Attributing to the vast patient population and the availability of
low-cost procedures and drugs to treat the disease, the already growing markets
in India and China will lead the regional market.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Comments
Post a Comment